|
Gerard D. "Gerry" Wright, PhD, FRSC, is a professor in the Department of Biochemistry and Biomedical Sciences, and Canada Research Chair in Antibiotic Biochemistry at McMaster University〔(【引用サイトリンク】 title=Gerry's Bio )〕 who studies chemical compounds that can combat antibiotic resistance in bacteria.〔(【引用サイトリンク】 title=Canada Research Chair in Molecular Studies of Antibiotics )〕 He is also an Associate member of the Departments of Chemistry and Chemical Biology and Pathology and Molecular Medicine. Wright was Chair of the Department of Biochemistry and Biomedical Sciences from 2001-2007 before becoming the Director of McMaster's Michael G. DeGroote Institute for Infectious Disease Research. He is founding director of the McMaster Antimicrobial Research Centre, and co-founder of the McMaster High Throughput Screening Facility. Wright obtained his BSc in Biochemistry and his PhD in Chemistry from the University of Waterloo. He did his post-doctoral training at Harvard Medical School before joining McMaster University in 1993. Wright is a Fellow of the Royal Society of Canada and the American Academy of Microbiology. He currently serves as an associate editor of ''ACS Infectious Diseases'', and he is a member of the editorial boards of ''Chemistry and Biology'', ''The Journal of Antibiotics'', ''Annals of the New York Academy of Sciences'', and ''Antimicrobial Therapeutics Reviews''. Wright coined the term antibiotic resistome, which is used to describe the collection of all the antibiotic resistant genes and their precursors in both pathogenic and non-pathogenic bacteria. In 2014, Wright was the senior author on a study in ''Nature'' which described the discovery that the previously known Aspergillomarasmine A was a new antibiotic.〔 ==References== 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Gerry Wright (biochemist)」の詳細全文を読む スポンサード リンク
|